Delivery Order SPE2DB22D2108-SPE2DB25FU5DS
- Not listed
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $5,393.88 to Amerisourcebergen Drug Corp, a leading global pharmaceutical distributor, for the provision of Advair HFA 115-21 mcg inhalers. This delivery order, with a period of performance through April 2, 2024, is issued under an indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00 that enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide an Advair HFA 230-21 MCG inhaler with a potential value of $6,549.48. This order has a completion date of February 6, 2024 and was awarded on February 5, 2024. The place of performance is Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a for-profit organization that serves as a prime contractor to DLA, providing a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gram units) with a ceiling value of $9,743.54. This competitive award, with a firm fixed price structure and no set-aside designation, is scheduled for completion by July 21, 2025. The contract represents a continuation of the company's pharmaceutical supply services under its existing Indefinite Delivery Contract with DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,960.17, is for the supply of Advair HFA 230-21 mcg inhalers. It is a firm fixed-price delivery order with a performance period extending to May 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of Advair HFA 230-21 MCG Inhaler 12GM. The $3,099.87 firm-fixed-price contract has a completion date of July 31, 2024 and is not set aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $6,431.62 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product, with a performance period through April 11, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Advair HFA 115-21 MCG inhalers. The contract has a ceiling value of $2,440.08 and a completion date of August 12, 2024. It is a firm-fixed-price contract and was not set aside for any special designation. As one of the largest pharmaceutical distributors in the United States, AmerisourceBergen has been awarded numerous federal contracts to provide a wide range of prescription...
- The Defense Logistics Agency has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $2,082.64 to supply Advair HFA 115-21 mcg inhalers. The contract has a performance period through January 30, 2024 and does not utilize a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and is a for-profit organization based in Conshohocken, Pennsylvania. This delivery order contract is part of a larger...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Advair HFA 115-21 MCG inhalers. The $6,390.24 order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Advair HFA 230-21 MCG Inhaler 12GM medication. The $3,975.72 contract has a performance period through March 26, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is placed against a $999,999,999.00 indefinite delivery contract (IDC)...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5DSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,747.80 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle with the DLA. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major healthcare solutions provider and pharmaceutical distributor. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates consistent capability in fulfilling diverse pharmaceutical procurement needs for defense and veteran healthcare systems through competitively awarded contracts with firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.7k | 7/18/25 |